Krüppel-Like Factor 4 Acts as an Oncogene in Colon Cancer Stem Cell-Enriched Spheroid Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Leng, Zhengwei ^a   Tao, Kaixiong ^a   Xia, Qinghua ^a   Tan, Jun ^a   Yue, Zhongyi ^a   Chen, Jinhuang ^a   Xi, Hailin ^a   Li, Jie ^a   Zheng, Hai ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; SHORT HAIRPIN RNA; ALCAM PROTEIN, HUMAN; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD133 ANTIGEN; FETOPROTEIN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN; ISOENZYME; KRUPPEL LIKE FACTOR; LEUKOCYTE ANTIGEN; LGR5 PROTEIN, HUMAN; NERVE CELL ADHESION MOLECULE; ONCOPROTEIN; PEPTIDE; RETINAL DEHYDROGENASE;

ADHERENT CELL; ADULT; ADULT STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CELL RENEWAL; CELL TYPE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; GENE ACTIVITY; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KRUPPEL LIKE FACTOR 4 GENE; MOUSE; NONHUMAN; ONCOGENE; PLURIPOTENT STEM CELL; SOMATIC CELL; SPHEROID CELL; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CELL STRAIN HCT116; CELL STRAIN HT29; CELL TRANSFORMATION; COLON TUMOR; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FEMALE; FETAL PROTEINS; GLYCOPROTEINS; HCT116 CELLS; HT29 CELLS; HUMANS; ISOENZYMES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS; PEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RETINAL DEHYDROGENASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS;

EID: 84873903291     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056082     Document Type: Article

References (61)

1. O'Connell JB, Maggard MA, Ko CY, (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96: 1420-1425.
2. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, et al. (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8: 773-783.
3. Dean M, Fojo T, Bates S, (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284.
4. Dalerba P, Cho RW, Clarke MF, (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267-284.
5. Hart LS, El-Deiry WS, (2008) Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. J Clin Oncol 26: 2901-2910.
6. Tang SN, Fu J, Nall D, Rodova M, Shankar S, et al. (2012) Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer 131: 30-40.
7. Deng S, Yang X, Lassus H, Liang S, Kaur S, et al. (2010) Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 5: e10277.
8. Zeki SS, Graham TA, Wright NA, (2011) Stem cells and their implications for colorectal cancer. Nat Rev Gastroenterol Hepatol 8: 90-100.
9. Kobayashi S, Yamada-Okabe H, Suzuki M, Natori O, Kato A, et al. (2012) LGR5-Positive Colon Cancer Stem Cells Interconvert with Drug Resistant LGR5-Negative Cells and are Capable of Tumor Reconstitution. Stem Cells.
10. Carpentino JE, Hynes MJ, Appelman HD, Zheng T, Steindler DA, et al. (2009) Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. Cancer Res 69: 8208-8215.
11. Hart LS, Dolloff NG, Dicker DT, Koumenis C, Christensen JG, et al. (2011) Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab. Cell Cycle 10: 2331-2338.
12. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
13. Bellizzi A, Sebastian S, Ceglia P, Centonze M, Divella R, et al. (2013) Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis. J Cell Physiol 228: 408-415.
14. Levin TG, Powell AE, Davies PS, Silk AD, Dismuke AD, et al. (2010) Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract. Gastroenterology 139: 2072-2082 e2075.
15. Wilson BJ, Schatton T, Frank MH, Frank NY, (2011) Colorectal Cancer Stem Cells: Biology and Therapeutic Implications. Curr Colorectal Cancer Rep 7: 128-135.
16. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, et al. (2008) CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15: 2927-2933.
17. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, et al. (2006) Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24: 506-513.
18. Cui X, Oonishi K, Tsujii H, Yasuda T, Matsumoto Y, et al. (2011) Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. Cancer Res 71: 3676-3687.
19. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, et al. (2008) Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One 3: e2428.
20. Fan X, Liu S, Su F, Pan Q, Lin T, (2012) Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol Oncol 30: 314-318.
21. Michishita M, Akiyoshi R, Yoshimura H, Katsumoto T, Ichikawa H, et al. (2011) Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines. Res Vet Sci 91: 254-260.
22. Wei B, Han XY, Qi CL, Zhang S, Zheng ZH, et al. (2012) Coaction of spheroid-derived stem-like cells and endothelial progenitor cells promotes development of colon cancer. PLoS One 7: e39069.
23. Rybak AP, He L, Kapoor A, Cutz JC, Tang D, (2011) Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochim Biophys Acta 1813: 683-694.
24. Lobo NA, Shimono Y, Qian D, Clarke MF, (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699.
25. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163.
26. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
27. Clark PA, Iida M, Treisman DM, Kalluri H, Ezhilan S, et al. (2012) Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Neoplasia 14: 420-428.
28. Yu F, Li J, Chen H, Fu J, Ray S, et al. (2011) Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 30: 2161-2172.
29. Dang DT, Chen X, Feng J, Torbenson M, Dang LH, et al. (2003) Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene 22: 3424-3430.
30. Wei D, Kanai M, Huang S, Xie K, (2006) Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27: 23-31.
31. Ghaleb AM, McConnell BB, Nandan MO, Katz JP, Kaestner KH, et al. (2007) Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res 67: 7147-7154.
32. Zhang W, Chen X, Kato Y, Evans PM, Yuan S, et al. (2006) Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 26: 2055-2064.
33. An J, Golech S, Klaewsongkram J, Zhang Y, Subedi K, et al. (2011) Kruppel-like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL-17 expression during Th17 differentiation. FASEB J 25: 3634-3645.
34. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, et al. (2002) The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129: 2619-2628.
35. Li Y, McClintick J, Zhong L, Edenberg HJ, Yoder MC, et al. (2005) Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105: 635-637.
36. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
37. O'Leary DP, Bhatt L, Woolley JF, Gough DR, Wang JH, et al. (2012) TLR-4 signalling accelerates colon cancer cell adhesion via NF-kappaB mediated transcriptional up-regulation of Nox-1. PLoS One 7: e44176.
38. Liu W, Wang G, Cao X, Luo X, Li Z, et al. (2012) Down-regulation of p110beta expression increases chemosensitivity of colon cancer cell lines to oxaliplatin. J Huazhong Univ Sci Technolog Med Sci 32: 280-286.
39. Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, et al. (2009) C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol 218: 57-65.
40. Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, et al. (2011) CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Mullerian tumor). Stem Cells 29: 1485-1495.
41. Kato J, Zhu J, Liu C, Stylianou M, Hoffmann V, et al. (2011) ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis. Cancer Res 71: 5327-5335.
42. Hirsch HA, Iliopoulos D, Joshi A, Zhang Y, Jaeger SA, et al. (2010) A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 17: 348-361.
43. Fan X, Ouyang N, Teng H, Yao H, (2011) Isolation and characterization of spheroid cells from the HT29 colon cancer cell line. Int J Colorectal Dis 26: 1279-1285.
44. Feng Y, Dai X, Li X, Wang H, Liu J, et al. (2012) EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. Cell Prolif 45: 413-419.
45. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, et al. (2004) Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23: 395-402.
46. Tiwari N, Gheldof A, Tatari M, Christofori G, (2012) EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 22: 194-207.
47. Gao D, Vahdat LT, Wong S, Chang JC, Mittal V, (2012) Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 72: 4883-4889.
48. Chen ZY, Shie J, Tseng C, (2000) Up-regulation of gut-enriched kruppel-like factor by interferon-gamma in human colon carcinoma cells. FEBS Lett 477: 67-72.
49. Tirino V, Desiderio V, d'Aquino R, De Francesco F, Pirozzi G, et al. (2008) Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One 3: e3469.
50. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, et al. (2009) Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 106: 16281-16286.
51. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
52. Yin S, Li J, Hu C, Chen X, Yao M, et al. (2007) CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 120: 1444-1450.
53. Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ, et al. (2012) CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med 10: 85.
54. Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, et al. (2009) Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res 15: 4299-4311.
55. Elsaba TM, Martinez-Pomares L, Robins AR, Crook S, Seth R, et al. (2010) The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLoS One 5: e10714.
56. Yori JL, Johnson E, Zhou G, Jain MK, Keri RA, (2010) Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem 285: 16854-16863.
57. Shih JY, Yang PC, (2011) The EMT regulator slug and lung carcinogenesis. Carcinogenesis 32: 1299-1304.
58. Kanthan R, Senger JL, Kanthan SC, (2012) Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog Res Int 2012: 597497.
59. Satelli A, Li S, (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68: 3033-3046.
60. Zhang N, Zhang J, Shuai L, Zha L, He M, et al. (2012) Kruppel-like factor 4 negatively regulates beta-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer. Int J Oncol 40: 2038-2048.
61. Nam EH, Lee Y, Park YK, Lee JW, Kim S, (2012) ZEB2 upregulates integrin alpha5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells. Carcinogenesis 33: 563-571.